Fundraising Fox
James Rothman
InvestorSenior Advisor at Celesta Capital
Find your path to James
Sign up to see every warm intro you have to James
- Paths you didn't know you had: your email and LinkedIn already hold routes to James. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
A Nobel laureate (2013, medicine) and Lasker Award-winning biochemist, Rothman is the Sterling Professor of Cell Biology and Director of the Nanobiology Institute at Yale, and has held roles as chief scientist at GE Healthcare and Amersham Biosciences. At Celesta he serves as a senior advisor and board member for science-based portfolio companies such as Prellis and Atonarp.
Invests in
BiotechDeep TechHealthtech
Colleagues at Celesta Capital
Frequently asked questions
- Who is James Rothman?
- A Nobel laureate (2013, medicine) and Lasker Award-winning biochemist, Rothman is the Sterling Professor of Cell Biology and Director of the Nanobiology Institute at Yale, and has held roles as chief scientist at GE Healthcare and Amersham Biosciences. At Celesta he serves as a senior advisor and board member for science-based portfolio companies such as Prellis and Atonarp.
- Where does James Rothman work?
- James Rothman is Senior Advisor at Celesta Capital.
- What does James Rothman invest in?
- James Rothman invests in Biotech, Deep Tech, Healthtech.
About this profile. Compiled from public sources — Celesta Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights